Related Experiment Video
Updated: Jun 9, 2026
Robotic Enucleation of Esophageal Leiomyoma
Published on: February 20, 2026
Outcomes from leiomyoma therapies: comparison with normal controls
James B Spies1, Linda D Bradley, Richard Guido
1From Georgetown University Hospital Department of Radiology, Washington, DC; Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, Ohio; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, DC; and United BioSource Inc, Bethesda, Maryland.
Uterine fibroid treatments significantly reduced symptoms and improved quality of life for patients. Hysterectomy offered the greatest symptom relief and quality of life improvement compared to other therapies.
Area of Science:
- Gynecology
- Medical Research
- Quality of Life Studies
Background:
- Uterine leiomyomas cause significant symptoms and impact health-related quality of life.
- Assessing treatment outcomes is crucial for patient management.
Purpose of the Study:
- To evaluate the severity of uterine leiomyoma symptoms.
- To assess the impact of these symptoms on health-related quality of life.
- To compare treatment outcomes against a normal control group.
Main Methods:
- A multicenter, nonrandomized prospective study followed 375 patients for 12 months.
- Uterine Fibroid Symptom and Quality of Life (UFS-QOL) and Short Form 36 questionnaires were used.
- Patients underwent hysterectomy, myomectomy, or uterine artery embolization, alongside a normal control group.
Main Results:
- At baseline, leiomyoma patients had significantly higher symptom scores than controls (64.8 vs. 15.3).
- All treatments substantially reduced symptoms, with scores nearing normal levels by 12 months.
- Hysterectomy demonstrated superior symptom reduction and quality of life improvement compared to myomectomy and embolization.
Conclusions:
- All three uterine leiomyoma treatments provide significant symptom relief within 12 months.
- Treatment outcomes approach those of women without uterine fibroids.
- Hysterectomy yields the most substantial improvements in symptoms and quality of life.